Ekso Bionics Holdings, Inc. EKSO Cash Flow

Ekso bionics holdings, inc. (EKSO)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12
Operating activities:
Net loss
-2,534	-2,721	206	-3,066	-6,551	-4,132	-6,983	-7,976	-7,901	-8,978	-6,335	-5,507	-8,302	-5,576	-8,478	-5,765	-3,651	-4,645	-5,185	-5,645	-4,115	-20,155	12,024	56,128	-81,766	-6	3,375	-3,399	-3,796	-	-	-	-
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization
164	171	26	246	247	341	286	460	428	434	448	421	445	474	473	468	440	280	234	219	200	210	202	176	157	126	115	115	111	-	-	-	-
Provision for excess and obsolete inventories
23	37	5	5	19	30	4	27	130	73	0	0	0	-	-	-	-	-	-	-	45	-57	0	21	0	-	-	-	-	-	-	-	-
Changes in allowance for doubtful accounts
0	-11	13	-5	55	69	-10	-93	-16	5	45	55	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Gain) loss on revaluation of warrant liabilities
2,519	331	4,430	2,737	-1,122	1,225	-682	-212	732	-942	1,814	3,106	-69	-	-	-	2,985	2,505	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Gain on change in fair value of warrant liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,206	-15,773	-60,458	77,437	-	-	-	-	-	-	-	-
Adjustment to record convertible note at fair value
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-438	-360	-	-	-	-
Stock-based compensation expense
587	575	487	557	636	636	938	402	892	659	650	711	394	569	451	527	1,574	472	468	442	349	333	117	326	367	112	107	84	86	-	-	-	-
Amortization of debt discount and accretion of final payment fee
13	17	20	26	29	33	35	41	43	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	9	9	9	9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount and accretion of final payment fee
-	-	-	-	-	-	-	-	-	107	24	24	24	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-9	-9	-10	-9	-9	-9	-9	-8	-9	-9	-9	-	-	-	-
Amortization of debt discounts
-	-	-	-	-	-	-	-	-	-	22	20	21	-	-	-	-	-	-	-	-	17	-7	0	198	42	-139	128	137	-	-	-	-
Change in fair value of contingent liabilities
-	-	-	-	-	22	-4	-2	19	141	14	70	-12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock contribution to 401(k) plan
77	29	10	48	55	56	38	62	56	509	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on modification of warrants
0	0	0	0	-257	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized loss on foreign currency transactions
-219	251	-350	118	-152	-90	-57	-387	153	75	152	239	34	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on increase in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-33	0	0	-	-	-	-
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
-2,550	-9	677	743	188	741	-569	-120	798	597	106	914	-532	-271	634	-817	314	-59	-209	939	-94	-372	428	-282	1,226	-116	-251	16	111	-	-	-	-
Inventories
55	-698	-455	106	154	401	1,056	-88	286	857	403	366	470	-485	-304	-145	1,475	-179	-99	217	261	-515	-412	78	495	-237	361	-17	-4	-	-	-	-
Prepaid expenses, operating lease right-of-use assets, and other assets current and noncurrent
68	-274	-277	40	142	-215	-74	-378	-379	-756	1,496	-66	188	-34	-158	-46	298	-247	253	26	59	-44	33	-5	52	6	-55	97	39	-	-	-	-
Deferred costs of revenue
-	-	-	-	-	-	-	-	-	-	-	-	46	-92	92	-255	-4,335	246	-47	469	354	454	624	387	530	57	-96	176	304	-	-	-	-
Accounts payable
96	541	-1,118	6	-660	-306	848	-801	1,011	827	-1,078	-660	988	517	-715	-1,544	924	373	-158	842	681	-294	-150	182	-454	43	414	-454	234	-	-	-	-
Accrued and lease liabilities
37	-950	-287	269	-167	82	262	135	80	682	274	-31	-820	189	22	2	1,255	-305	214	319	-721	1,052	58	-301	135	0	-20	16	30	-	-	-	-
Deferred revenues
-312	-	114	420	113	-	-27	443	141	-13	326	-150	121	-290	463	-531	-6,585	335	-286	894	323	413	520	967	779	-103	232	92	942	-	-	-	-
Net loss for the period
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-23	-	-	-1	-4	-4
Increase (Decrease) in Accounts Payable and Accrued Liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4	-	-	-	-3	4
Net cash used in operating activities
-1,722	-1,495	-4,569	-4,531	-5,177	-5,154	-4,207	-6,059	-6,745	-5,644	-8,723	-9,605	-7,254	-	-	-	-	-	-	-	-	-	-	-	-	-1	-1	-27	-0	-1	-1	-8	-0
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7,333	-6,789	-	-4,620	-4,634	-3,828	-2,711	-3,691	-3,146	-5,459	-2,301	-1,147	-3,251	-2,362	-	-	-	-
Investing activities:
Note receivable from stockholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	0	0	0	-	-	-	-
Acquisition of property and equipment
0	0	0	53	7	80	20	0	31	103	105	110	138	368	131	312	285	530	403	278	281	570	242	427	248	329	-47	59	37	-	-	-	-
Net cash used in investing activities
0	0	0	-53	-7	-80	-20	0	-31	-103	-105	-110	-138	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing activities:
Fees paid related to 2015 issuance of convertible preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	173	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock and warrants, net
0	4,863	0	9,020	7,305	485	3,961	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-66	66	-26	21,987	-51	19	0	32	-5	0	0	5
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-312	-285	-	-403	-278	-281	-674	-138	-427	-248	-329	47	-59	-37	-	-	-	-
Proceeds from issuance of 2012 Series B convertible bridge notes, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	500	1,500	-	-	-	-
Principal payments on note payable
589	594	598	594	591	589	591	595	399	8	8	16	22	21	2	37	19	20	18	11	11	49	3	12	2,532	782	148	461	436	-	-	-	-
Proceeds from exercise of stock options
0	0	0	173	55	0	1	0	0	4	0	18	24	36	17	29	28	145	24	25	31	102	-23	0	23	-	-	-	-	-	-	-	-
Proceeds from exercise of common stock warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	4	16	32	21,412	0	0	0	-	-	-	-	-	-	-	-
Proceeds from Contributions from Affiliates
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	5	3
Net cash (used in) provided by financing activities
-589	4,269	-598	8,599	6,769	-104	3,371	-595	-399	109	31,536	10,921	2	-	-	-	-	-	-	-	-	-	-	-	-	1	0	0	-0	19	8	5	8
Effect of exchange rate changes on cash
-45	-	-	-	-4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash
-2,356	-	-	-	1,581	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock, net of repurchases and issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	52	-	-	-	-
Net cash provided by (used in) financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-8	-164	-	10	30	52	21,399	40	-38	19,478	3,209	1,173	3,010	1,116	-	-	-	-
Effect of exchange rate changes on cash
-	-	-	-	-	-	-39	-28	-66	12	30	69	-30	86	-6	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash
-	-	-	-	-	-	-895	-6,682	-7,241	-5,626	22,738	1,275	-7,420	4,046	8,139	-7,653	-7,238	8,314	-5,013	-4,882	-4,057	18,014	-3,789	-3,611	13,771	-0	-1	-27	-1,283	17	7	-3	8
Supplemental disclosure of cash flow activities
Cash paid for interest
32	-232	72	87	96	-332	112	119	119	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for income taxes
3	301	0	8	0	457	0	-16	16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	632	-11	11	0	-	-	-	-
Cash paid for income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-110	-121	121	135	-	-	-	-
Supplemental disclosure of non-cash activities
Initial recognition of operating lease right-of-use assets
0	0	0	0	1,454	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Initial recognition of operating lease liabilities
0	0	0	0	1,498	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Transfer of inventory to property and equipment
38	118	-78	-323	206	361	73	336	348	-	-79	289	207	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Share issuance for common stock contribution to 401(k) plan
155	0	0	0	191	0	0	0	508	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Share issuance in lieu of cash compensation
50	0	0	919	0	61	0	40	190	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equipois sales earn-out
0	0	0	0	22	0	0	0	28	0	0	47	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cumulative retrospective adjustment to retained earnings for ASU 2016-09 adoption
-	-	-	-	-	-	-	-	-	0	0	0	171	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of convertible preferred stock to common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6,285	6,285	0	0	-	-	-	-